ENDOCUR - Modulation of Endotoxaemia Via Curcumin Intake in Healthy Overweight Adults

University of Glasgow

Status

Completed

Conditions

Overweight

Treatments

Dietary Supplement: BCM-95

Dietary Supplement: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT03329781

200130089

Details and patient eligibility

About

Chronic diseases such as diabetes, cardiovascular diseases and cancer are a major burden on the Scottish population. Obesity and inflammation have strong links to these diseases. One of the mechanisms explaining the relationship between low-grade inflammation and excess weight is "endotoxaemia". We wish to study this phenomenon, when small components coming from our gut bacteria can pass into the bloodstream, raising the body's defences. Diet can modulate endotoxaemia. In this study, we propose to use curcumin, in a capsule form, to modulate endotoxaemia. Curcumin comes from turmeric, which is widely used as a spice. In this study, we want to test the effect of consuming curcumin extract to the composition of the gut microbiota, post-meal endotoxaemia, and inflammatory markers in blood.

Enrollment

16 patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

BMI > 25 kg/m2.

Exclusion criteria

having chronic inflammatory or autoimmune disease, gastrointestinal complaints or known biliary obstruction (past and present)
use of anti-inflammatory drugs 2 weeks before the start of the study
use of antibiotics during the 12 weeks preceding the trial
pregnancy
lactation